137 related articles for article (PubMed ID: 12428493)
1. [Safety of monoclonal antibody anti-CD 20 in refractory thrombocytopenic idiopathic purpura].
de Roux Serratrice C; Brandi Y; Caillères S; Brunel V; Allègre T; Blanc AP
Rev Med Interne; 2002 Oct; 23(10):869-70. PubMed ID: 12428493
[No Abstract] [Full Text] [Related]
2. Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children.
Roganovic J
Eur J Pediatr; 2005 May; 164(5):334. PubMed ID: 15711954
[No Abstract] [Full Text] [Related]
3. [Good response to treatment with rituximab in a child with refractory idiopathic thrombocytopenic purpura].
Fríguls-Francitorra B; Almazán-Castro F; Manchón GJ
Med Clin (Barc); 2006 Sep; 127(12):478-9. PubMed ID: 17040639
[No Abstract] [Full Text] [Related]
4. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
Gómez-Almaguer D
Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
[TBL] [Abstract][Full Text] [Related]
5. Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab.
El-Shanawany TM; Williams PE; Jolles S
J Clin Pathol; 2007 Jun; 60(6):715-6. PubMed ID: 17483248
[No Abstract] [Full Text] [Related]
6. Sustained response to anti-CD20 monoclonal antibody in severe acute primary immune thrombocytopenic purpura: report of one adult case.
Luzzatto G; Cella G; Fabris F
Clin Appl Thromb Hemost; 2006 Jan; 12(1):120-1. PubMed ID: 16444448
[No Abstract] [Full Text] [Related]
7. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in children with idiopathic thrombocytopenic purpura: does it really work?
Russo G; Licciardello M; La Spina M
Eur J Pediatr; 2004 Sep; 163(9):569. PubMed ID: 15243812
[No Abstract] [Full Text] [Related]
9. Successful use of rituximab in Evans syndrome and refractory immune thrombocytopenic purpura.
Kashif M; Qureshi A; Adil SN; Khurshid M
J Pak Med Assoc; 2010 Jan; 60(1):64-5. PubMed ID: 20055286
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for patients with idiopathic thrombocytopenic purpura.
Peñalver FJ; Cabrera JR
Ann Intern Med; 2007 Aug; 147(4):281; author reply 281-2. PubMed ID: 17709765
[No Abstract] [Full Text] [Related]
11. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
[TBL] [Abstract][Full Text] [Related]
12. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
Cooper N; Evangelista ML; Amadori S; Stasi R
Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
[TBL] [Abstract][Full Text] [Related]
13. Use of rituximab in chronic childhood immune thrombocytopenic purpura.
Bay A; Oner AF; Uner A; Dogan M
Pediatr Int; 2006 Oct; 48(5):514-6. PubMed ID: 16970796
[No Abstract] [Full Text] [Related]
14. Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus.
Hundae A; Peskoe S; Grimsley E; Patel S
South Med J; 2008 Sep; 101(9):943-4. PubMed ID: 18708978
[TBL] [Abstract][Full Text] [Related]
15. Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia.
Oo TH
South Med J; 2005 Dec; 98(12):1227-8. PubMed ID: 16440930
[No Abstract] [Full Text] [Related]
16. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
17. Slow responses to standard dose rituximab in immune thrombocytopenic purpura.
Kelly K; Gleeson M; Murphy PT
Haematologica; 2009 Mar; 94(3):443-4; author reply 444-5. PubMed ID: 19252177
[No Abstract] [Full Text] [Related]
18. Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura.
Bengtson KL; Skinner MA; Ware RE
J Pediatr; 2003 Nov; 143(5):670-3. PubMed ID: 14615744
[TBL] [Abstract][Full Text] [Related]
19. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis.
Thude H; Gruhn B; Werner U; Schorner U; Häfer R; Zintl F; Barz D
Acta Haematol; 2004; 111(4):221-4. PubMed ID: 15153715
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
Chemnitz JM; Uener J; Hallek M; Scheid C
Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
